Academic Journal
Q1Diabetologia
About Diabetologia
Diabetologia is a scholarly journal published by Springer Science and Business Media Deutschland GmbH. SCImago 2025 places it in Q1 with an SJR of 3.858 and an H-index of 276.
Its listed coverage is 1965-2026 and its research categories include Endocrinology, Diabetes and Metabolism (Q1); Internal Medicine (Q1). The 2025 dataset reports 257 documents and 5906 citations across the latest three-year reporting window.
Diabetologia is a prestigious, peer-reviewed scientific journal dedicated to publishing cutting-edge research in the field of diabetes. As one of the most influential journals in the realm of diabetes and endocrinology, it serves as a vital resource for scientists, clinicians, and healthcare professionals worldwide. Published by the European Association for the Study of Diabetes (EASD), Diabetologia has become a go-to source for high-quality research related to diabetes, ranging from molecular biology and genetics to clinical care and public health.
What is Diabetologia?
Diabetologia, which means "study of diabetes" in Greek, has been at the forefront of diabetes research since its establishment. The journal covers a broad spectrum of topics, including the mechanisms of diabetes, prevention strategies, therapeutic interventions, and emerging technologies in diabetes care. It provides an in-depth look at both type 1 and type 2 diabetes, making it an essential resource for anyone working in the field of diabetes research and care.
Key Areas of Focus in Diabetologia
-
Diabetes Pathophysiology: One of the core focuses of Diabetologia is the investigation of the underlying mechanisms of diabetes. Research articles delve into the molecular and cellular processes that lead to insulin resistance, beta-cell dysfunction, and the other biological pathways involved in diabetes development.
-
Clinical Research: Diabetologia also places a significant emphasis on clinical studies. Researchers and clinicians alike benefit from the journal’s focus on practical applications, such as new treatment options, clinical trials, and the management of diabetes complications. This includes innovations in medication, lifestyle interventions, and personalized medicine approaches.
-
Epidemiology and Public Health: The journal publishes research related to the epidemiology of diabetes, offering insights into global trends, risk factors, and public health initiatives aimed at preventing and managing diabetes. This is particularly relevant as the prevalence of diabetes continues to rise worldwide.
-
Technological Advances: Diabetologia frequently highlights advances in diabetes technology, such as continuous glucose monitoring (CGM), insulin pumps, and the role of artificial intelligence in diabetes management. These innovations are reshaping how diabetes is monitored and treated, and the journal serves as a key platform for disseminating these developments.
-
Diabetes Complications: The journal also explores the long-term complications of diabetes, such as cardiovascular disease, neuropathy, and retinopathy. Understanding these complications is critical to improving patient outcomes and developing effective treatments to prevent or delay their onset.
Why Diabetologia is Important for Diabetes Researchers and Healthcare Professionals
For researchers, Diabetologia is an essential platform for sharing groundbreaking studies. Its impact factor, a measure of the journal's reputation and influence in the scientific community, reflects its importance in advancing the field of diabetes research. Healthcare professionals rely on Diabetologia to stay informed about the latest developments in diabetes care and treatment, ensuring they provide evidence-based care to their patients.
How Diabetologia Contributes to Diabetes Awareness
In addition to publishing high-quality research, Diabetologia plays a significant role in raising awareness about diabetes at the global level. By providing a forum for the exchange of ideas and findings, the journal helps drive discussions about diabetes prevention, treatment, and management. This, in turn, promotes a better understanding of the disease among the medical community and the general public.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
Diabetologia is a renowned scientific journal that focuses on the study of diabetes, its management, and the underlying mechanisms involved in the disease. It plays a crucial role in advancing research on diabetes, providing insights into the latest discoveries, innovations, and treatments. This journal serves as a valuable resource for both researchers and healthcare professionals dedicated to tackling the global diabetes epidemic.
The Importance of Diabetologia in Diabetes Research
Diabetes is one of the most widespread chronic diseases affecting millions of individuals worldwide. As a result, there is a growing need for advanced research to understand the complexities of the disease and improve the effectiveness of its management. Diabetologia contributes significantly to this field by publishing high-quality research articles, reviews, and clinical studies that offer fresh perspectives and solutions.
The scope of Diabetologia covers various aspects of diabetes research, including:
-
Etiology and Pathogenesis of Diabetes
Diabetologia explores the underlying causes and mechanisms behind the development of diabetes. Researchers investigate genetic, environmental, and lifestyle factors that contribute to both Type 1 and Type 2 diabetes. Understanding the pathophysiology of diabetes is crucial for identifying preventive measures and new treatment strategies. -
Diabetes Prevention and Early Diagnosis
Early detection and intervention are key to preventing the complications associated with diabetes. Diabetologia emphasizes research on the identification of biomarkers, early screening techniques, and lifestyle modifications that can reduce the risk of developing diabetes. The journal also delves into the role of public health initiatives in raising awareness about the disease. -
Diabetes Management and Treatment
Advances in diabetes treatment are a major focus of Diabetologia. The journal covers a wide range of therapeutic approaches, from insulin therapy to emerging drugs and devices. Studies on personalized medicine, diabetes control strategies, and the role of technology in diabetes management are integral to the journal’s scope. -
Complications of Diabetes
Diabetes can lead to various complications, including cardiovascular disease, neuropathy, kidney failure, and retinopathy. Diabetologia publishes research on how to manage and mitigate these complications, aiming to improve the quality of life for individuals with diabetes. -
Diabetes in Special Populations
The journal also highlights studies that focus on diabetes in specific populations, such as children, the elderly, and pregnant women. Understanding how diabetes affects different age groups and demographics allows for tailored treatment plans and better outcomes.
Recent Advances and Future Trends in Diabetologia
In recent years, Diabetologia has published numerous breakthrough studies that have revolutionized our understanding of diabetes. The growing interest in artificial intelligence, machine learning, and genomics has opened up new possibilities for precision medicine in diabetes care. The scope of Diabetologia continues to expand with a focus on cutting-edge technologies, novel drug therapies, and global health initiatives aimed at reducing the diabetes burden.
Moreover, the journal fosters collaboration between scientists, clinicians, and healthcare professionals worldwide, encouraging interdisciplinary approaches to tackle the diabetes crisis.
Recent Research Articles
Latest publications matched automatically by ISSN.
Preserved cardiac vagal tone is associated with nocturnal glycaemic stability
Maria Bitsch Poulsen, Simon Lebech Cichosz, Peter Julu, Johan Røikjer et al.
2026-09-09 · DOI: 10.1007/s00125-026-06844-wCorrection: Endometriosis subtypes and risk of type 2 diabetes: the Advancing Research on Cardiovascular Health and Endometriosis Study (ARCHES) retrospective cohort study
Maggie Fuzak Nunziato, Bin Yan, Karen C. Schliep, Leslie V. Farland et al.
2026-09-08 · DOI: 10.1007/s00125-026-06864-6Continuous glucose monitoring using the FreeStyle Libre Pro iQ in presymptomatic type 1 diabetes
Andreas Weiss, Elisabeth Huber, Franziska Reinmüller, Annette Munzinger et al.
2026-09-07 · DOI: 10.1007/s00125-026-06852-wAnne-Marie Felton, 1943–2026
Rita Forde, Kristin de Backer, Angus Forbes, Chantal Mathieu et al.
2026-09-05 · DOI: 10.1007/s00125-026-06867-3Single-cell profiling of pancreatic islets maps subtype-associated molecular alterations in type 2 diabetes
Xueqin Xie, Changchun Wu, Xinwei Luo, Yijie Wei et al.
2026-09-01 · DOI: 10.1007/s00125-026-06842-yGenetic association stratified by HLA-DR3 and HLA-DR4 status reveals heterogeneity in pathways of progression to type 1 diabetes
Amber M. Luckett, Carolyn McGrail, Kathryn Murrall, Emily N. Griffin et al.
2026-08-31 · DOI: 10.1007/s00125-026-06836-wExercise timing or feeding status? Interpreting glycaemic responses to resistance exercise in type 1 diabetes
Stuart R. Gray, Ameenah Al-Awadhi, Ebaa Al Ozairi
2026-08-31 · DOI: 10.1007/s00125-026-06850-yMetabolic and macrovascular outcomes following simultaneous pancreas–kidney transplantation and kidney transplantation alone in recipients with type 1 diabetes mellitus: a systematic review and meta-analysis
Harsham Choksi, Rowan Klein Nulend, Tess Cooper, Eric Au et al.
2026-08-29 · DOI: 10.1007/s00125-026-06843-xExercise timing or feeding status? Interpreting glycaemic responses to resistance exercise in type 1 diabetes. Reply to Gray S, Al-Awadhi A, Al-Ozairi E [letter]
Reid D. McClure, Normand G. Boulé, Jane E. Yardley
2026-08-29 · DOI: 10.1007/s00125-026-06851-xRotavirus vaccination and incidence of type 1 diabetes: a population-based natural experiment
Maria Östman, Ketil Størdal, German Tapia, Lars C. Stene et al.
2026-08-28 · DOI: 10.1007/s00125-026-06832-0A narrative review of what cohorts have taught us and how they have laid the foundation for much of our understanding of type 2 diabetes
Sun H. Kim, Ipsa Arora, Charles Agyemang, Ranjit M. Anjana et al.
2026-10 · DOI: 10.1007/s00125-026-06812-4Up Front
2026-10 · DOI: 10.1007/s00125-026-06854-8Divergent complication patterns of type 2 diabetes in African individuals who are lean versus overweight or obese: a multi-cohort analysis
Sabrina Esmail, Charles Hayfron-Benjamin, Samuel N. Darko, Ellis Owusu-Dabo et al.
2026-08-23 · DOI: 10.1007/s00125-026-06830-2Pancreatic islets: new discoveries for innovative treatments of diabetes?
Raphael Scharfmann, Arnaud Zaldumbide
2026-08-21 · DOI: 10.1007/s00125-026-06839-7William C. Knowler, MD, DrPH, 1946–2026
Paul W. Franks
2026-10 · DOI: 10.1007/s00125-026-06837-9Dulaglutide vs insulin in adolescents with thalassaemia-induced diabetes: effect on metabolism and atherogenesis (DIADEMA)
Amira Abdel Moneam Adly, Eman Abdel Rahman Ismail, Mohamed Salah Eldin Mohamed Abdel Kader, Manar Reda Sadeq et al.
2026-08-19 · DOI: 10.1007/s00125-026-06835-xA multi-centre study of belatacept and sirolimus for islet transplantation
Natasha M. Rogers, Min Hu, Elvira Jimenez-Vera, Hugh Gabor et al.
2026-10 · DOI: 10.1007/s00125-026-06813-3The liver in diabetes: current state and future perspectives
Hannele Yki-Järvinen, Michael Roden
2026-08-15 · DOI: 10.1007/s00125-026-06827-xDiminished arginine bioavailability during hyperglycaemia distinguishes individuals with A−β+ ketosis-prone diabetes from those with type 2 diabetes: implications for the pathogenesis of ketoacidosis in A−β+ ketosis-prone diabetes
Jean W. Hsu, Adriana Elizondo, Absalon Gutierrez, Eunice Caducoy et al.
2026-08-14 · DOI: 10.1007/s00125-026-06834-yDevelopment and application of type 1 diabetes polygenic scores across diverse populations
Despoina Manousaki, Dominika A. Michalek, Hui-Qi Qu, Lauric A. Ferrat et al.
2026-08-12 · DOI: 10.1007/s00125-026-06831-1Reviews
Community Reviews
Version History
April 23, 2025 at 8:49 am
April 23, 2025